29 December 2016 - Donald Trump and Hillary Clinton agreed on almost nothing during the 2016 presidential campaign — but they did agree that the U.S. needs to address unaffordable prescription drug prices. And the public also supports this idea. 

A survey released in October 2016 showed that 64% of voters, including 52% of Republicans, believe that the federal government should place a “limit on how much pharmaceutical companies can increase prescription drug prices.”

Further, 73% of all voters (68% of Republicans) concur that the federal government should be able to negotiate with drug companies to lower Medicare drug prices for seniors. While the November 8 federal election results have dampened prospects for policy change along these lines, does anyone believe that this issue now will disappear?

Read Health Affairs blog